Clinical study of nimotuzumab combined with concurrent radiochemotherapy for treatment of locally advanced cervical cancer

PURPOSE: Nimotuzumab is a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR) to inhibit tumor growth. Nimotuzumab has demonstrated desirable therapeutic activity in various types of tumors. However, the benefit of nimotuzumab for the treatment of cervical cancer i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Manag Res
Asıl Yazarlar: Chen, Wenli, Li, Tao, Wang, Jian, Liang, Long, Huang, Dandan, Yan, Gaoshu, Tian, Ye, Zhang, Xiaoli, Zhang, Wei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6731987/
https://ncbi.nlm.nih.gov/pubmed/31564975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S191134
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller